Curriculum Vitae Adam C. Olson, MD

Transcription

1 Curriculum Vitae Adam C. Olson, MD I. BIOGRAPHICAL Work Address: 5230 Centre Avenue Pittsburgh, PA Work Phone: II. EDUCATION A. Graduate 2015-Present Duke University M.Sc., Global Health Durham, NC University of Pittsburgh Doctor of Medicine 2012 Pittsburgh, PA B. Post-Baccalaureate Pre-Medical Studies San Jose State University San Jose, CA 2006 Santa Clara University Santa Clara, CA C. Undergraduate Loyola Marymount University B.A., Film Production 2003 Los Angeles, CA

2 Adam C. Olson, MD Curriculum Vitae 2 III. WORK EXPERIENCE 2017-Present Clinical Assistant Professor Department of Radiation Oncology UPMC Hillman Cancer Center Research Associate RW Stearns, Inc. San Francisco, CA IV. POSTDOCTORAL TRAINING Resident Physician Chief Resident, Department of Radiation Oncology Duke University Medical Center Durham, NC Chairman: Christopher Willett, MD Residency Director: W. Robert Lee, MD Transitional Year Intern, Internal Medicine Chief Intern UPMC Presbyterian Shadyside Hospital Pittsburgh, PA V. LICENSURE 2018-Present Pennsylvania (#MD ) North Carolina (#RTL ) VI. MEMBERSHIPS in PROFESSIONAL and SCIENTIFIC SOCIETIES 2014-Present 2010-Present 2010-Present American Society of Clinical Oncology American Society for Radiation Oncology American Brachytherapy Society VII. HONORS 2017 Global Health Scholar, ASTRO/ARRO 2016 ACRO GROW Travel Scholarship Greater Horn Oncology Symposium; Mwanza, Tanzania 2012 Alpha Omega Alpha Honor Society

3 Adam C. Olson, MD Curriculum Vitae Merit Scholarship, 2009 Radiological Society of North America Trainee Research Prize RSNA Annual Meeting; Chicago, IL 2003 magna cum laude, Loyola Marymount University Presidential Scholarship, Loyola Marymount University Dean s List, Loyola Marymount University Honors Society, Loyola Marymount University VIII. PUBLICATIONS A. Peer-Reviewed Articles 1. Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: risk factors, feasibility of dose reduction via re-optimization, and patient outcomes. Birer SR,* Olson AC,* Adamson J, Hood R, Susen M, Kim G, Salama JK, Kirkpatrick JP. Med Dosim Jul 28. pii: S (17) * = co-first authors. 2. Grover S, Gudi S, Gandhi AK, Puri P, Olson A, Rodin D, Balogun O, Dhillon P, Sharma DN, Rath GK, Shrivastava SK, Viswanathan AN, Mahantshetty U. Radiation Oncology in India: Challenges and Opportunities. Semin Radiat Oncol Apr;27(2): Qin R, Olson AC, Singh B, Peterson B, Thomas S, Wolf S, Bhavsar N, Hanks B, Salama JK, Salama AK. Safety and efficacy of radiation in advanced melanoma patients treated with ipilimumab. Int J Radiat Oncol Biol Phys Sep 1;96(1): Olson AC, Thomas S, Qin R, Singh B, Salama JK, Kirkpatrick JP, Salama AK. Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab. Melanoma Management Sep;3(3): Olson AC, Coleman CN, Hahm SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S. A Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys Nov 93(3): Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei YM, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training Global Oncologists: Addressing the Global Cancer Control Problem. Front Oncol Apr 8;5:80. Pubmed ID Gill BS, Kim H, Houser C, Olson AC*, Kelley J, Edwards RP, Comerci J, Sukumvanich P, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy Nov-Dec;13(6): Pubmed ID * = misspelled as Olsen A on Pubmed. 8. Olson AC, Wegner RE, Rwigema JC, Heron DE, Burton SA, Mintz AH. Reirradiation of Brain Metastases from Small Cell Lung Cancer with Linear Accelerator Based Radiosurgery. J Cancer Res Ther Jul-Sep;8(3): PubMed ID Kim CH, Olson AC, Beriwal S, Kim H. Contouring Inguinal and Femoral Nodes How Much Margin is Needed Around the Vessels? Practical Radiation Oncology Oct;2(4), PubMed ID

4 Adam C. Olson, MD Curriculum Vitae Olson AC, Wegner RE, Scicutella C, Heron DE, Greenberger JS, Huq S, Bednarz G, Flickinger JC. Quality Assurance Analysis of a Large Multicenter Practice: Does Increased Complexity of Intensity Modulated Radiotherapy Lead to Increased Error Frequency? Int J Radiat Oncol Biol Phys April 14. PubMed ID Wegner RE, Olson AC, Kondziolka D, Lunsford DL, Flickinger JC. Stereotactic Radiosurgery for Patients with Brain Metastases from Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys Feb 22. PubMed ID B. Articles Under Consideration 1. Olson AC, Craciunescu O, Meltsner S, Cai J, Cheng JZ, Chino JP. Dosimetry, feasibility, and acute toxicity of combined intracavitary and free-hand interstitial needle brachytherapy for locally advanced gynecologic malignancies. IX. SEMINARS and INVITED LECTURESHIPS RELATED to RESEARCH A. Oral Presentations 1. Sperduto PW, Deegan BJ, Jethwa KR, Lockey N, Beal K, Rana NG, Attia A, Shanley R, Lou E, Zahra A, Buatti JM, Molitoris JK, Yu JB, Chiang V, Masucci L, Roberge D, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Shi D, Shih HA, Mehta M. Prognostic Factors in Patients with Renal Cell Carcinoma and Brain Metastases. ASTRO Annual Meeting; 2017 Sep 24; San Diego, CA. 2. Kirkpatrick JP, Olson AC, Limon D, Boyle J, Kim G, Floyd S, Fecci P, Yin FF, Sampson J. Understanding and Optimizing Clinical Outcomes in Stereotactic Radiosurgery. Innovations in Radiation Engineered Therapy; 2016 Nov 14-15; Toronto, ON. 3. Mowery YM, Patel KP, Olson AC, Khan M, Salama AK. Toxicity and Survival for Metastatic Melanoma Patients Treated with Anti-PD1 Therapy and Radiation Treatment. ASTRO Annual Meeting; 2016 Sep 28; Boston, MA. 4. Olson AC, Craciunescu O, Meltsner S, Cai J, Cheng JZ, Chino JP. Dosimetry, Feasibility, and Acute Toxicity of Combined Intracavitary Brachytherapy and Free-Hand Interstitial Needle Placement for Locally Advanced Cervix and Uterine Cancer. World Congress of Brachytherapy; 2016 Jun 27-29; San Francisco, CA. 5. Kim CH, Olson AC, Beriwal S, Kim H. Contouring Inguinal and Femoral Nodes How Much Margin is Needed Around the Vessels? ASTRO Annual Meeting; 2011 Oct 2-6; Miami, FL. 6. Wegner RE, Olson AC, Flickinger J, Kondziolka D, Lunsford D, Niranjan A. SRS for Patients with Brain Metastases from Small Cell Lung Cancer. Pennsylvania Radiologic Society; 2010 May 8; Pittsburgh, PA. 7. Olson AC, Beriwal S, Kim H, Houser C, Wegner RE, Heron DE, Richard SD, Kelley JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC, Olawaiye AB. 3D Treatment Planning for Medically Inoperable Endometrial Cancer: Dosimetric Analysis & Early Clinical Outcomes. Brachytherapy Annual Meeting; 2010 Apr 29-May 1; Atlanta, GA.

5 Adam C. Olson, MD Curriculum Vitae 5 B. Poster Presentations 1. Olson AC, Royce TJ, Longo J, Morris Z, Chino J, Coleman CN, Grover S. Early Career Outcomes for Radiation Oncologists Interested in Global Health: A Survey of Recent Graduates from ARRO, ACRO, and CARO. ASTRO Annual Meeting; 2017 Sep 26; San Diego, CA. 2. Olson AC, Patel KP, Mowery YM, Wynne J, Ready N, Kirkpatrick JP, Salama AK, Khan M. Anti-PD1 Therapy and Stereotactic Radiosurgery for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: a Two-Institution Series. ASTRO Annual Meeting; 2016 Sep 28; Boston, MA. 3. Birer S*, Olson AC*, Adamson J, Kim GK, Salama JK, Kirkpatrick JP. Hippocampal Dose from SRS for Four to Ten Brain Metastases: Risk Factors and Feasibility of Dose Reduction via Reoptimization. ASTRO Annual Meeting; 2016 Sep 28; Boston, MA. *: cofirst authors. 4. Schroeder K, Olson AC, Ackerson B, Larrier NL, Masalu N, Chao N, Likonda B. Radiation needs in pediatric oncology in the lake region of Tanzania. Symposium on Global Cancer Research, CUGH Annual Conference April; San Francisco, CA. 5. Qin R, Singh B, Olson AC, Bhavsar N, Wolf S, Salama JK, Kirkpatrick JP, Salama AK. Safety and efficacy of radiation in advanced melanoma patients treated with ipilimumab. Society for Melanoma Research 2015 Congress November 18-21, San Francisco, CA. 6. Olson AC, Qin R, Singh B, Bhavsar N, Wolf S, Salama JK, Kirkpatrick JP, Salama AK. Radiosurgery for Brain Metastases in Melanoma Patients Receiving Ipilimumab. ASTRO Annual Meeting; 2015 October 18-21; San Antonio, TX. 7. Olson AC, Das S, May R, Czito B, Kelsey C, Patel P. Normal Tissue Toxicity Risk Assessment with Interim 18F-FDG PET-CT in Patients with Non-Small Cell Lung Cancer Undergoing Radiotherapy. ASTRO Annual Meeting; 2014 Sept 14-17; San Francisco, CA. 8. Olson AC, Beriwal S, Kim H, Houser C, Wegner RE, Heron DE, Richard SD, Kelley JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC, Olawaiye AB. Dosimetry and Early Clinical Outcomes of 3D Treatment Planning for High Dose Rate Brachytherapy of Medically Inoperable Endometrial Cancer. ASTRO Annual Meeting; 2011 Oct 2-6; Miami, FL. 9. Olson AC, Heron DE, Kubicek G. PET-CT Performance Characteristics May Be Early Predictors of Recurrence in Head & Neck Cancers Treated with IMRT. ASTRO Annual Meeting; 2011 Oct 2-6; Miami, FL. 10. Olson AC, Wegner RE, Scicutella C, Heron DE, Greenberger JS, Huq S, Bednarz G, Flickinger JC. Quality Assurance Analysis of a Large Multicenter Practice: Does Increased Complexity of Intensity Modulated Radiotherapy Lead to Increased Error Frequency? ASTRO Annual Meeting; 2011 Oct 2-6; Miami, FL. 11. Olson AC, Heron DE, Flickinger JC, Kubicek G, Ferris RL, Gibson MK. Impact of PET-CT on Outcomes for Squamous Cell Carcinomas of the Head and Neck. ASTRO Multidisciplinary Head & Neck Cancer Symposium; 2010 Feb 25-27; Chandler, AZ.

6 Adam C. Olson, MD Curriculum Vitae Olson AC, Wegner RE, Scicutella C, Heron DE, Bednarz G, Huq S, Flickinger JC. A Quality Assurance Analysis of Reported Events for a Single Institution s Radiation Oncology Department. RSNA Annual Meeting; 2009 Nov 29-Dec 4; Chicago, IL. C. Other Invited Presentations 1. Olson AC. Implementation Research Opportunities in Oncology in Tanzania. Greater Horn Oncology Symposium; 2016 Jun 4; Mwanza, Tanzania. 2. Olson AC, Wegner RE, Scicutella C, Heron DE, Greenberger JS, Huq S, Bednarz G, Flickinger JC. Quality Assurance Analysis of a Large Multicenter Practice: Does Increased Complexity of Intensity Modulated Radiotherapy Lead to Increased Error Frequency? Department of Radiation Oncology Pre-Staff Meeting; 2011 Jan 23; Pittsburgh, PA. X. RESEARCH INTERESTS 1. Oncology implementation research in low- and middle-income countries 2. Cancer disparities and cost effectiveness 3. Stereotactic radiosurgery and immunotherapy for brain metastases XI. PROFESSIONAL ACTIVITIES A. Grants ARRO-ASTRO Global Health Scholar Award. Title: The Impact of Radiation Therapy Access on Cancer Incidence Reporting in Tanzania. Mentor: Kristin Schroeder, MD. Duke University. $ Dean s Summer Research Grant. Mentor: Dwight E. Heron, MD, FACRO. University of Pittsburgh School of Medicine. $3000. B. Research Activities 1. Scholarly Project: SUV & Treatment Response Assessment of Head and Neck Squamous Cell Carcinoma Mentors: Dwight E. Heron, MD, FACRO. Pittsburgh, PA. A retrospective study of tumor response to radiotherapy utilizing quantitative assessment of standardized uptake values in serial PET-CT scans of head and neck cancer patients. XII. MEDICAL STAFF PROFESSIONAL DEVELOPMENT Samuel Ross Birer, Duke University, Research, Mentee XIII. SERVICE Program Director, GHOS Summit 2016, Mwanza, Tanzania 2015-Present ABS International Subcommittee Member 2015-Present Invited Reviewer Int J Radiat Biol Physics, Dis Esophagus, JAMA Oncology, Brachytherapy

7 Adam C. Olson, MD Curriculum Vitae Present Board Member, Radiating Hope Society 2015-Present ARRO Global Health Subcommittee Member Co-Founder and Co-President, Oncology Interest Group Co-Editor, Murmurs Arts and Literature Magazine Medical School Applicant Interviewer 2008 Street Member Volunteer, Operation Safety Net Volunteer, Dialysis Unit El Camino Hospital; Mountain View, CA